The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kim I.A.

N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Ragimova D.R.

Pirogov National Research Medical University

Features of adherence to treatment of patients with chronic rhinosinusitis with nasal polyps

Authors:

Kim I.A., Nosulya E.V., Ragimova D.R.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2022;87(1): 81‑86

DOI: 10.17116/otorino20228701181

Read: 1506 times

Download PDF (RU)
Contact the author
Table of contents

FEATURES OF ADHERENCE TO TREATMENT OF PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
FEATURES OF ADHERENCE TO TREATMENT OF PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

To cite this article:

Kim IA, Nosulya EV, Ragimova DR. Features of adherence to treatment of patients with chronic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology. 2022;87(1):81‑86. (In Russ.)
https://doi.org/10.17116/otorino20228701181

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Chronic polypous rhinosinusitis (CPR) is characterized by refractory to drug therapy and a high potential for recurrence after surgical treatment. One of the important factors limiting the effectiveness of drug therapy of CPR, in particular intranasal glucocorticosteroids (inGCSs), is the insufficient level of adherence to treatment of patients with CPR.

OBJECTIVE

Generalization of data on the significance and ways to increase adherence to treatment of patients with CPR.

MATERIAL AND METHODS

Materials of scientific publications included in the Cochrane Library, Russian Science Citation Index, MEDLINE, PubMed information bases were used as a data source. The material was selected based on the following keywords: “chronic rhinosinusitis”, “nasal polyps”, “intranasal glucocorticosteroids”, “adherence to treatment”.

RESULTS

Despite the fact that inGCSs are one of the main pathogenetically justified methods of treating CPR, their use is limited by many factors, one of which is the level of patient compliance with the treatment regimen.

CONCLUSION

Improving adherence to treatment is one of the important reserves for increasing the effectiveness of drug therapy for chronic polypous rhinosinusitis.

Keywords:

chronic rhinosinusitis
nasal polyps
intranasal glucocorticosteroids
adherence to treatment

Authors:

Kim I.A.

N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Ragimova D.R.

Pirogov National Research Medical University

Received:

27.10.2021

Accepted:

24.12.2021

Close metadata

References:

  1. Mygind N, Nielsen LP, Hoffmann HJ, Shukla A, Blumberga G, Dahl R, Jacobi H. Mode of action of intranasal corticosteroids. The Journal of Allergy and Clinical Immunology. 2001;108(1 Suppl): 16-25.  https://doi.org/10.1067/mai.2001.115561
  2. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-300.  https://doi.org/10.1111/j.1398-9995.2008.01750.x
  3. Passali D, Cingi C, Cambi J, Passali F, Muluk NB, Bellussi ML. A survey on chronic rhinosinusitis: opinions from experts of 50 countries. European Archives of Oto-Rhino-Laryngology. 2016;273(8):2097-2109. https://doi.org/10.1007/s00405-015-3880-6
  4. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AG. Different types of intranasal steroids for chronic rhinosinusitis. The Cochrane Database of Systematic Reviews. 2016;4: CD011993. https://doi.org/0.1002/14651858.CD011993.pub2
  5. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. Journal of Investigational Allergology and Clinical Immunology. 2012;22(1):1-12. 
  6. Bachert C. Evidence-based management of nasal polyposis by intranasal corticosteroids: from the cause to the clinic. International Archives of Allergy and Immunology. 2011;155(4):309-21.  https://doi.org/10.1159/000321406
  7. DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. The Laryngoscope. 2017;127(3):550-555.  https://doi.org/10.1002/lary.26391
  8. Lu PC, Lee TJ, Huang CC, Chang PH, Chen YW, Fu CH. Serum eosinophil cationic protein: a prognostic factor for early postoperative recurrence of nasal polyps. International Forum of Allergy and Rhinology. 2021;11(4):766-772.  https://doi.org/10.1002/alr.22664
  9. Wynn R, Har-El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. The Laryngoscope. 2004;114(5): 811-813.  https://doi.org/10.1097/00005537-200405000-00004
  10. Kim IA, Nosulya EV. Improvement of pathogenetic correction of postoperative changes of the nasal mucosa in modern rhinosurgery. Rossijskaya otorinolaringologiya. 2009;38(1):184-187. (In Russ.).
  11. Vennik J, Eyles C, Thomas M, Hopkins C, Little P, Blackshaw H, Schilder A, Boardman J, Philpott CM. Management strategies for chronic rhinosinusitis: A qualitative study of GP and ENT specialist views of current practice in the UK. BMJ Open. 2018;8(12): e022643. https://doi.org/10.1136/bmjopen-2018-022643
  12. Gray R. Concordance Skills Manual (Version IV). London: The Bethlem & Maudsley NHS Trust. Institute of Psychiatry; 2003.
  13. Rudd P. Medication compliance: correlation with clinical outcomes. P and T. 1994;19:10-18. 
  14. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics. 2001;26(5):331-342.  https://doi.org/10.1046/j.1365-2710.2001.00363.x
  15. Hill M, Houston N. Adherence to antihypertensive therapy. 2007; Chapter 131:390-392. 
  16. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. The American Journal of Medicine. 2005;118(Suppl 5A):27-34.  https://doi.org/10.1016/j.amjmed.2005.04.012
  17. Sabaté E, ed. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
  18. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J; VA Naltrexone Study Group 425. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value in Health. 2003;6(5):566-573.  https://doi.org/10.1046/j.1524-4733.2003.65269.x
  19. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22): 2880-2883. https://doi.org/10.1001/jama.288.22.2880
  20. Benner JS, Glynn RJ, Mogun H, Neu-mann PJ, Weinstein MC, Avorn J. Long-termpersistence in use of statin therapy in elderlypatients. JAMA. 2002;288(4):455-461.  https://doi.org/10.1001/jama.288.4.455
  21. Waeber B, Leonetti G, Kolloch R,McInnes GT. Compliance with aspirin orplacebo in the Hypertension Optimal Treatment (HOT) study. Journal of Hypertension. 1999;17(7):1041-1045. https://doi.org/10.1097/00004872-199917070-00022
  22. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations betweendose regimens and medication compliance. Clinical Therapeutics. 2001;23(8):1296-1310. https://doi.org/10.1016/s0149-2918(01)80109-0
  23. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adversedrug reactions. The Annals of Pharmacotherapy. 2002;36(9):1331-1336. https://doi.org/10.1345/aph.1A333
  24. Senst BL, Achusim LE, Genest RP, Cosentino LA, Ford CC, Little JA, Raybon SJ, Bates DW. Practical approach to determining costs and frequency of adverse drug events in a health care network. American Journal of Health-System Pharmacy: AJHP. 2001;58(12):1126-1132. https://doi.org/10.1093/ajhp/58.12.1126
  25. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462-467.  https://doi.org/10.1001/jama.288.4.462
  26. Chernyak BA, Nosulya EV, Sekretareva LB, Kim IA. Influence of nasal corticosteroid therapy duration on its efficiency at nasal polyposis. Pul’monologiya. 2005;2:107-112. (In Russ.). https://doi.org/10.18093/0869-0189-2005-0-2-107-112
  27. Phillips KM, Hoehle LP, Caradonna DS, Gray ST, Sedaghat AR. Intranasal corticosteroids and saline: Usage and adherence in chronic rhinosinusitis patients. The Laryngoscope. 2020;130(4): 852-856.  https://doi.org/10.1002/lary.28152
  28. Philpott C, Erskine S, Smith R, Hopkins C, Kara N, Farboud A, Salam M, Robertson A, Almeyda R, Kumar BN, Anari S, Ray J, Cathcart R, Carrie S, Ahmed S, Khalil H, Clark A, Thomas M; CRES group. Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES). Clinical Otolaryngology. 2018;43(2): 509-524.  https://doi.org/10.1111/coa.13012
  29. Nabi S, Rotenberg BW, Vukin I, Payton K, Bureau Y. Nasal spray adherence after sinus surgery: problems and predictors. Journal of Otolaryngology — Head and Neck Surgery. 2012;41(Suppl 1):49-55. 
  30. Shen SA, Jafari A, Qualliotine JR, DeConde AS. Follow-Up Adherence Is Associated with Outcomes after Endoscopic Sinus Surgery. The Annals of Otology, Rhinology, and Laryngology. 2020; 129(7):707-714.  https://doi.org/10.1177/0003489420908291
  31. Goldbeck L, Fidika A, Herle M, Quittner AL. Psychological interventions for individuals with cystic fibrosis and their families. The Cochrane Database of Systematic Reviews. 2014;2014(6): CD003148. https://doi.org/10.1002/14651858.CD003148.pub3
  32. Mendes R, Martins S, Fernandes L. Adherence to Medication, Physical Activity and Diet in Older Adults with Diabetes: Its Association With Cognition, Anxiety and Depression. Journal of Clinical Medicine Research. 2019;11(8):583-592.  https://doi.org/10.14740/jocmr3894
  33. Jneid S, Jabbour H, Hajj A, Sarkis A, Licha H, Hallit S, Khabbaz LR. Quality of Life and Its Association with Treatment Satisfaction, Adherence to Medication, and Trust in Physician among Patients with Hypertension: A Cross-Sectional Designed Study. Journal of Cardiovascular Pharmacology and Therapeutics. 2018;23(6):532-542.  https://doi.org/10.1177/1074248418784292
  34. Philpott C, Erskine S, Hopkins C, Coombes E, Kara N, Sunkareneni V, Anari S, Salam M, Farboud A, Clark A; CRES Group. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis. Rhinology. 2016;54(2):134-140.  https://doi.org/10.4193/Rhino15.272
  35. Chung JH, Lee YJ, Kang TW, Kim KR, Jang DP, Kim IY, Cho SH. Altered Quality of Life and Psychological Health (SCL-90-R) in Patients with Chronic Rhinosinusitis with Nasal Polyps. The Annals of Otology, Rhinology, and Laryngology. 2015;124(8):663-670.  https://doi.org/10.1177/0003489415576181
  36. Osterberg L, Blaschke T. Adherence to medication. The New England Journal of Medicine. 2005;353(5):487-497.  https://doi.org/10.1056/NEJMra050100
  37. Cook CL, Wade WE, Martin BC, Perri M III. Concordance among three self-reported measures of medication adherence and pharmacy refill records. Journal of the American Pharmacists Association: JAPhA. 2005;45(2):151-159.  https://doi.org/10.1331/1544345053623573
  38. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Medical Care. 1999; 37(9):846-857.  https://doi.org/10.1097/00005650-199909000-00002
  39. Gossec L, Tubach F, Dougados M, Ravaud P. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. The American Journal of the Medical Sciences. 2007;334(4):248-254.  https://doi.org/10.1097/MAJ.0b013e318068dde8
  40. Katwa U, Rivera E. Asthma Management in the Era of Smart-Medicine: Devices, Gadgets, Apps and Telemedicine. Indian Journal of Pediatrics. 2018;85(9):757-762.  https://doi.org/10.1007/s12098-018-2611-6
  41. Demiris G, Afrin LB, Speedie S, Courtney KL, Sondhi M, Vimarlund V, Lovis C, Goossen W, Lynch C. Patient-centered applications: use of information technology to promote disease management and wellness. A white paper by the AMIA knowledge in motion working group. Journal of the American Medical Informatics Association: JAMA. 2008;15(1):8-13.  https://doi.org/10.1197/jamia.M2492
  42. Sun DL, Li RL. The application of mobile medicine in the prevention and control of chronic diseases. Chinese Journal of Tissue Engineering Research. 2016;20(40):6074-6080.
  43. Bi J, Yang W, Hao P, Zhao Y, Wei D, Sun Y, Lin Y, Sun M, Chen X, Luo X, Li S, Zhang W, Wang X. WeChat as a Platform for Baduanjin Intervention in Patients with Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial. JMIR mHealth and uHealth. 2021;9(2):e23548. https://doi.org/10.2196/23548
  44. Zhang Q, Ding FM, Bao JL. Influence of attribution intervention based on WeChat on self-management level of hypertension patients in community. China Medical Herald. 2017;28:162-165. 
  45. Dong Y, Wang P, Dai Z, Liu K, Jin Y, Li A, Wang S, Zheng J. Increased self-care activities and glycemic control rate in relation to health education via Wechat among diabetes patients: a randomized clinical trial. Medicine. 2018;97(50):e13632. https://doi.org/10.1097/MD.0000000000013632
  46. Wu P, Wan Y, Zhuang Y, Wang C, Xi S, Zhu H. WeChat-based vestibular rehabilitation for patients with chronic vestibular syndrome: protocol for a randomised controlled trial. BMJ Open. 2021;11(3):e042637. https://doi.org/10.1136/bmjopen-2020-042637
  47. Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos PA, Camuzat T, Carlsen KH, Carr W, Cepeda Sarabia AM, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fink Wagner A, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grouse L, Guzmán MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, Koffi N’Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O’Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation. Allergy. 2015;70(11):1372-1392. https://doi.org/10.1111/all.12686
  48. Feng S, Liang Z, Zhang R, Liao W, Chen Y, Fan Y, Li H. Effects of mobile phone WeChat services improve adherence to corticosteroid nasal spray treatment for chronic rhinosinusitis after functional endoscopic sinus surgery: A 3-month follow-up study. European Archives of Oto-Rhino-Laryngology. 2017;274(3):1477-1485. https://doi.org/10.1007/s00405-016-4371-0
  49. Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. The Annals of Otology, Rhinology, and Laryngology. 2011;120(7):423-427.  https://doi.org/10.1177/000348941112000701
  50. Håkansson K, Thomsen SF, Konge L, Mortensen J, Backer V, von Buchwald C. A comparative and descriptive study of asthma in chronic rhinosinusitis with nasal polyps. American Journal of Rhinology and Allergy. 2014;28(5):383-387.  https://doi.org/10.2500/ajra.2014.28.4076
  51. Rix I, Håkansson K, Larsen CG, Frendø M, von Buchwald C. Management of chronic rhinosinusitis with nasal polyps and coexisting asthma: A systematic review. American Journal of Rhinology and Allergy. 2015;29(3):193-201.  https://doi.org/10.2500/ajra.2015.29.4178
  52. Promsopa C, Kansara S, Citardi MJ, Fakhri S, Porter P, Luong A. Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes. International Forum of Allergy and Rhinology. 2016;6(4):373-377  https://doi.org/10.1002/alr.21674
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.